Correlation Between Algernon Pharmaceuticals and ATyr Pharma

Can any of the company-specific risk be diversified away by investing in both Algernon Pharmaceuticals and ATyr Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Algernon Pharmaceuticals and ATyr Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Algernon Pharmaceuticals and ATyr Pharma, you can compare the effects of market volatilities on Algernon Pharmaceuticals and ATyr Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Algernon Pharmaceuticals with a short position of ATyr Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Algernon Pharmaceuticals and ATyr Pharma.

Diversification Opportunities for Algernon Pharmaceuticals and ATyr Pharma

0.34

Correlation Coefficient

Algernon Pharmaceuticals  ATyr Pharma

Weak diversification

The 3 months correlation between Algernon and ATyr is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Algernon Pharmaceuticals and ATyr Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ATyr Pharma and Algernon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Algernon Pharmaceuticals are associated (or correlated) with ATyr Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ATyr Pharma has no effect on the direction of Algernon Pharmaceuticals i.e., Algernon Pharmaceuticals and ATyr Pharma go up and down completely randomly.

Pair Corralation between Algernon Pharmaceuticals and ATyr Pharma

If you would invest (100.00) in ATyr Pharma on September 23, 2024 and sell it today you would earn a total of  100.00  from holding ATyr Pharma or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	0.0%
Values	Daily Returns

Algernon Pharmaceuticals  vs.  ATyr Pharma

Algernon Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Algernon Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Algernon Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

ATyr Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ATyr Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, ATyr Pharma is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Algernon Pharmaceuticals and ATyr Pharma

The main advantage of trading using opposite Algernon Pharmaceuticals and ATyr Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Algernon Pharmaceuticals position performs unexpectedly, ATyr Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATyr Pharma will offset losses from the drop in ATyr Pharma's long position.

The idea behind Algernon Pharmaceuticals and ATyr Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.